For In Vitro Research Use Only — Not for Human or Veterinary Application.
Tirzepatide
For In Vitro Research Use Only – Not for Human or Veterinary Application
For In Vitro Research Use Only
Not for Human or Veterinary Application
Tirzepatide is a synthetic dual agonist peptide that targets both the glucose-dependent insulinotropic polypeptide (GIP) receptor and the glucagon-like peptide-1 (GLP-1) receptor. It is a 39-amino acid acylated peptide belonging to the incretin mimetic class of research compounds. Tirzepatide is studied in the context of metabolic signaling, insulin secretion pathways, adipogenesis, and energy homeostasis in in vitro and preclinical research models.
Tirzepatide acts as a co-agonist at both the GIP receptor (GIPR) and GLP-1 receptor (GLP-1R), which are G protein-coupled receptors involved in cAMP-mediated signaling cascades that modulate insulin secretion, glucagon suppression, and gastric motility. Research involving tirzepatide has focused on dual incretin receptor activation, pancreatic beta-cell function, adipocyte lipid metabolism, and hypothalamic appetite-regulating circuits in preclinical models. Published research has examined differential receptor bias between GIPR and GLP-1R activation pathways using this compound as a pharmacological tool.
This compound is intended strictly for in vitro laboratory research by qualified professionals.
It is not approved for:
By purchasing from Axis Peptide Labs, the buyer confirms that they are a qualified researcher, laboratory, or institution and acknowledge that the product is for research use only.
Discount Applied Successfully!
Your savings have been added to the cart.